⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Asthma and COPD Drugs Market to Grow from USD 33.16 Billion in 2025 to USD 56.21 Billion by 2035, at a CAGR of 5.42% - SNS Insider
globenewswire.com
AZN
PFE
GSK
NVS
Breast Cancer Continues to Impact Communities; Fort Worth Rallies Together to Take Action at Susan G. Komen® MORE THAN PINK Walk
businesswire.com
BAC
NTRA
GH
LLY
NVS
Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsight
prnewswire.com
ABBV
AMGN
BMY
NVS
PFE
UNH
Global Aplastic Anemia Industry Trends and Growth Outlook 2025-2035 Featuring Profiles of Pfizer, Novartis, and Sanofi
globenewswire.com
PFE
NVS
SNY
2026 Complement Inhibitors Market Analysis Report (2nd Edition) Featuring Amgen, CSL Behring, Innovent Biologics, Novartis, Regeneron, Roche, Sanofi, Takeda, UCB
globenewswire.com
AMGN
CSL
NVS
REGN
SNY
UCB
AZN
IONS
TEVA
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
prnewswire.com
NVS
BOC Group Named a Challenger in the 2026 Gartner® Magic Quadrant™ for Digital Twin of an Organization Platforms
prnewswire.com
CSCO
NVS
BOC Group Named a Challenger in the 2026 Gartner® Magic Quadrant™ for Digital Twin of an Organization Platforms
prnewswire.com
CSCO
NVS
Chondrosarcoma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
globenewswire.com
INBX
LLY
PFE
NVS
BMY
EXEL
JNJ
AZN
JAZZ
TLRY
THE SKIN OF COLOR SOCIETY (SOCS) UNITES 21 GLOBAL ORGANIZATIONS TO ADVANCE SKIN OF COLOR DERMATOLOGY
prnewswire.com
NVS